[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100561372":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":19,"centralContacts":24,"locations":30,"responsibleParty":69,"collaborators":10,"id":71,"slug":72,"hasResults":73,"nctId":74,"briefTitle":75,"officialTitle":76,"acronym":10,"eligibilityCriteria":77,"healthyVolunteers":78,"sex":79,"minAge":80,"maxAge":81,"enrollmentInfo":82,"targetDuration":10,"studyType":85,"phases":10,"briefSummary":86,"conditions":87,"keywords":10,"overallStatus":33,"whyStopped":10,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Exact Sciences Corporation","INDUSTRY",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"Multicancer Early Detection (MCED) cohort",null,[12],"Device: Exact Sciences Multicancer Early Detection (MCED) Test",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"DEVICE","Exact Sciences Multicancer Early Detection (MCED) Test","Exact Sciences MCED test, is a qualitative in vitro diagnostic (IVD) for the detection of alterations in circulating tumor DNA and tumor-associated protein levels, which are commonly associated with cancer. It is performed on plasma derived from peripheral blood specimens.",[9],[20],{"name":21,"affiliation":22,"role":23},"Tomasz M Beer, MD","Exact Sciences","PRINCIPAL_INVESTIGATOR",[25],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},"Deb Kettner-Sieber","CONTACT","608-982-6734","dkettnersieber@exactsciences.com",[31,53],{"facility":32,"status":33,"city":34,"state":35,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Endeavor Health","RECRUITING","Evanston","Illinois","60201","United States","US",{"type":40,"coordinates":41},"Point",[42,43],-87.69006,42.04114,{"lat":43,"lon":42},[46,49,52],{"name":47,"role":27,"phone":10,"phoneExt":10,"email":48},"Peter Hulick, M.D.","PHulick@northshore.org",{"name":50,"role":27,"phone":10,"phoneExt":10,"email":51},"Henry (Mark) Dunnenberger, PharmD","MDunnenberger@northshore.org",{"name":47,"role":23,"phone":10,"phoneExt":10,"email":10},{"facility":54,"status":33,"city":55,"state":56,"zip":57,"country":37,"countryCode":38,"cosmosGeoPoint":58,"geoPoint":62,"contacts":63},"Baylor Scott & White Health","Dallas","Texas","75246",{"type":40,"coordinates":59},[60,61],-96.80667,32.78306,{"lat":61,"lon":60},[64,67],{"name":65,"role":27,"phone":10,"phoneExt":10,"email":66},"Keisha Riser, MBA","Keisha.Riser@BSWhealth.org",{"name":68,"role":23,"phone":10,"phoneExt":10,"email":10},"Ronan Kelly, M.D.",{"type":70,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100561372","falcon-real-world-evidence-registry-100561372",false,"NCT06589310","Falcon Real World Evidence Registry","Falcon - The Exact Sciences Multicancer Early Detection (MCED) Real World Evidence (RWE) Registry","Inclusion Criteria:\n\n* Participant age at time of consent is between 50 and 80 years\n* Agree to receive the Exact Sciences MCED test and follow-up imaging\n* Willing and able to provide informed consent\n* Access to a suitable technology and willing to complete surveys electronically\n\nExclusion Criteria:\n\n* Any invasive tumor (excluding non-melanoma skin cancers) or hematological malignancy in the previous three years or current suspicion of cancer and\u002For in active treatment (e.g., chemotherapy, radiation therapy, immunotherapy, and\u002For surgery",true,"ALL","50 Years","80 Years",{"count":83,"type":84},25000,"ESTIMATED","OBSERVATIONAL","This is a multi-site registry of patients receiving the Exact Sciences Multicancer Early Detection (MCED) test.",[88],"Cancer","2026-05-20",{"date":91,"type":92},"2026-05-22","ACTUAL",{"date":94,"type":92},"2024-08-01",{"date":96,"type":84},"2031-01",{"name":5,"class":6},2]